Innate Pharma Files 6-K Report
Ticker: IPHA · Form: 6-K · Filed: 2026-04-02T06:01:47-04:00
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer
TL;DR
Innate Pharma filed a 6-K on 4/2/26. Standard reporting.
AI Summary
Innate Pharma SA filed a 6-K report on April 2, 2026. The filing includes exhibit EX-99.1 and a complete submission text file. The company's mailing and business address is in Marseille, France.
Why It Matters
This filing indicates ongoing regulatory compliance and reporting for Innate Pharma SA, a company involved in biological products.
Risk Assessment
Risk Level: low — This is a routine foreign issuer report (6-K) and does not contain specific financial or operational news that would indicate elevated risk.
Key Players & Entities
- Innate Pharma SA (company) — Filer of the 6-K report
- 0001598599 (company) — CIK number for Innate Pharma SA
- 2026-04-02 (date) — Filing date of the 6-K report
- EX-99.1 (document) — Exhibit included in the filing
FAQ
What type of report is Innate Pharma SA filing?
Innate Pharma SA is filing a Form 6-K, which is a Report of foreign issuer.
When was this 6-K filing accepted by the SEC?
The filing was accepted on April 2, 2026.
What is the CIK number for Innate Pharma SA?
The CIK number for Innate Pharma SA is 0001598599.
Where is Innate Pharma SA located?
Innate Pharma SA's mailing and business address is 117 AVENUE DE LUMINY BP 30191 MARSEILLE FRANCE.
What is the SIC code associated with Innate Pharma SA?
The SIC code is 2836, which corresponds to Biological Products, (No Diagnostic Substances).
From the Filing
EDGAR Filing Documents for 0001628280-26-022913 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001628280-26-022913 Filing Date 2026-04-02 Accepted 2026-04-02 06:01:47 Documents 2 Period of Report 2026-04-02 Document Format Files Seq Description Document Type Size 1 6-K a6k-iphx260402.htm 6-K 8467 2 EX-99.1 exhibit991-260402.htm EX-99.1 12586 Complete submission text file 0001628280-26-022913.txt 22438 Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE FRANCE France 13009 Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE FRANCE France 13009 33430303030 Innate Pharma SA (Filer) CIK : 0001598599 (see all company filings) EIN. : 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231 LEI: 9695002Y8420ZB8HJE29 Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 26830469 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)